Omnicell Stock Drop Followed Short Seller's Report, Suit Says
Medication automator Omnicell was hit with a proposed investor class action in California federal court over a 13% stock drop following a critical report on the company's financials from a research...To view the full article, register now.
Already a subscriber? Click here to view full article